GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Price-to-Free-Cash-Flow

BB Biotech AG (BB Biotech AG) Price-to-Free-Cash-Flow : 17.66 (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Price-to-Free-Cash-Flow?

As of today (2024-05-15), BB Biotech AG's share price is $76.05789. BB Biotech AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.31. Hence, BB Biotech AG's Price-to-Free-Cash-Flow Ratio for today is 17.66.

The historical rank and industry rank for BB Biotech AG's Price-to-Free-Cash-Flow or its related term are showing as below:

BBAGF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.22   Med: 10.88   Max: 85.54
Current: 9.9

During the past 13 years, BB Biotech AG's highest Price-to-Free-Cash-Flow Ratio was 85.54. The lowest was 4.22. And the median was 10.88.

BBAGF's Price-to-Free-Cash-Flow is ranked better than
75% of 216 companies
in the Biotechnology industry
Industry Median: 32.39 vs BBAGF: 9.90

BB Biotech AG's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $4.31.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of BB Biotech AG was -5.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -5.60% per year.

During the past 13 years, BB Biotech AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 50.00% per year. The lowest was -25.80% per year. And the median was 0.50% per year.


BB Biotech AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for BB Biotech AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Price-to-Free-Cash-Flow Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.57 14.26 - 15.33 16.18

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.33 16.58 19.16 22.24 16.18

Competitive Comparison of BB Biotech AG's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, BB Biotech AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Price-to-Free-Cash-Flow falls into.



BB Biotech AG Price-to-Free-Cash-Flow Calculation

BB Biotech AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=76.05789/4.306
=17.66

BB Biotech AG's Share Price of today is $76.05789.
BB Biotech AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.31.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

BB Biotech AG  (GREY:BBAGF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


BB Biotech AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (BB Biotech AG) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines